The Seventh Door

le Halmos, Balazs
Foilsithe 2014

Emerging uses of biomarkers in lung cancer management

le Halmos, Balazs, Levy, Benjamin
Foilsithe in Ann Transl Med (2017)

Expanding the gamut of circulating tumor DNA applications

le Kaumaya, Meghan, Halmos, Balazs
Foilsithe in J Thorac Dis (2018)

Capmatinib and gefitinib combination therapy: will EGFR-mutated MET-dysregulated NSCLC “capitulate”?

le Ko, Brian, Halmos, Balazs
Foilsithe in Transl Lung Cancer Res (2018)

VEGF inhibitors in EGFR-mutated lung cancer: a never-ending story?

le Alexander, Mariam, Halmos, Balazs
Foilsithe in Ann Transl Med (2018)

Update in Lung Cancer and Oncological Disorders 2010

le Halmos, Balazs, Powell, Charles A.
Foilsithe 2011

Choosing the best first-line therapy: NSCLC with no actionable oncogenic driver

le Kim, So Yeon, Halmos, Balazs
Foilsithe in Lung Cancer Manag (2020)

Has MET met its match?

le Borczuk, Alain, Paucar, Daniel, Halmos, Balazs
Foilsithe in Ann Transl Med (2016)

EGFR T790M: revealing the secrets of a gatekeeper

le Ko, Brian, Paucar, Daniel, Halmos, Balazs
Foilsithe in Lung Cancer (Auckl) (2017)

Emerging uses of biomarkers in lung cancer management: molecular mechanisms of resistance

le Attarian, Shirin, Rahman, Numa, Halmos, Balazs
Foilsithe in Ann Transl Med (2017)

Is pembrolizumab monotherapy the optimal treatment for elderly patients with PD-L1 positive advanced non-small cell lung cancer?

le Mienko, Fiona, Halmos, Balazs, Cheng, Haiying
Foilsithe in Ann Transl Med (2020)

Update in Lung Cancer 2014

le Spira, Avrum, Halmos, Balazs, Powell, Charles A.
Foilsithe in Am J Respir Crit Care Med (2015)

Update in Lung Cancer 2015

le Spira, Avrum, Halmos, Balazs, Powell, Charles A.
Foilsithe in Am J Respir Crit Care Med (2016)

MET/HGF pathway activation as a paradigm of resistance to targeted therapies

le Ko, Brian, He, Tianfang, Gadgeel, Shirish, Halmos, Balazs
Foilsithe in Ann Transl Med (2017)

Changes in store for early-stage non-small cell lung cancer

le Sandler, Jason E., D’Aiello, Angelica, Halmos, Balazs
Foilsithe in J Thorac Dis (2019)

Local consolidative therapy in metastatic non-small cell lung cancer

le Patel, Gunj, Halmos, Balazs, Cheng, Haiying, Ohri, Nitin
Foilsithe in J Thorac Dis (2019)

Dysregulation of the C/EBPα Differentiation Pathway in Human Cancer

le Koschmieder, Steffen, Halmos, Balazs, Levantini, Elena, Tenen, Daniel G.
Foilsithe 2009

Update in Lung Cancer and Mesothelioma 2012

le Powell, Charles A., Halmos, Balazs, Nana-Sinkam, Serge P.
Foilsithe 2013

The Structure and Clinical Relevance of the EGF Receptor in Human Cancer

le Kumar, Amit, Petri, Edward T., Halmos, Balazs, Boggon, Titus J.
Foilsithe 2008

Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1

le Li, Guangyuan, Wang, Xiaoqi, Hibshoosh, Hanina, Jin, Cheng, Halmos, Balazs
Foilsithe 2014